Global oncofertility index-data gap slows progress

Saskia F de Roo1, Alexandra S Rashedi2, Catharina C M Beerendonk3

  • 1Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, The Netherlands; Northwestern University, Chicago, Illinois, USA.

Insights

Developing a global oncofertility index (OFI) to assess reproductive loss in cancer survivors is currently unachievable due to data limitations. This prevents meaningful comparisons and evaluation of oncofertility care worldwide.

Area of Science:

  • Oncology
  • Reproductive Medicine
  • Public Health

Background:

  • Increasing numbers of pediatric and young adult cancer survivors globally.
  • Growing concern regarding cancer-related infertility and reproductive hormone loss in survivors.
  • Need for standardized metrics to evaluate oncofertility care and outcomes.

Purpose of the Study:

  • To estimate reproductive loss in oncofertility-practicing countries.
  • To develop a global oncofertility index (OFI) for national comparisons.
  • To assess the urgency and current management of oncofertility issues.

Main Methods:

  • Exploratory analysis of existing global data on cancer survivorship and reproductive health.
  • Conceptual framework development for a potential global oncofertility index.
  • Identification of data gaps and limitations for index calculation.

Main Results:

  • The development of a meaningful global oncofertility index is currently unachievable.
  • Significant data deficiencies exist regarding country-specific reproductive loss metrics.
  • Lack of standardized data prevents comprehensive assessment and comparison of oncofertility care.

Conclusions:

  • The absence of necessary data precludes the creation of a global oncofertility index.
  • Without such a metric, assessing oncofertility care progress and learning from international best practices is hindered.
  • Further efforts are needed to collect standardized data to address reproductive health concerns in cancer survivors.

Related Concept Videos

Infertility in Females01:28

Infertility in Females

Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
4.9K
Infertility in Males01:23

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
620
In Vitro Fertilization01:24

In Vitro Fertilization

In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
1.1K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
805
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K